Sunesis publish modified SNS-032 analogs « Kinase News

Blogroll
Tags
AstraZeneca aurora Avastin bayer Bcr-Abl bevacizumab BMS c-kit cetuximab EGFR ErbB-2 ErbB2 erbitux Exelixis Genentech GlaxoSmithKline Gleevec GSK HER1 HER2 IGF-1R Imatinib ImClone JAK2 kinase Merck-Serono Met mTOR multikinase Nexavar Novartis onyx PDGF Pfizer phase I Phase II phase iii PI3K Preclinical regulatory Research Roche sorafenib VEGF VEGFR2
Providing a resource for information on kinase inhibitors

Sunesis publish modified SNS-032 analogs

Posted on October 3, 2008 by crimsoncanary

Sunesis have published a series of modified SNS-032 analogs

Filed under: Uncategorized | Tagged: CDK, kinase, Preclinical, Research, Sunesis

« Boehringer Ingelheim publish series of ITK inhibitors Vorinostat enhances MK-0457 activity in AML/CML »